이식형 제세동기(ICD) 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 유형별, NYHA 분류별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Implantable Cardioverter Defibrillator Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Product, By Type, By NYHA Class, By End-User, By Region, Competition, 2020-2030F

US $ 4,500 ￦ 6,699,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,188,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,910,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 이식형 제세동기(ICD) 시장은 2024년에 36억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 6.53%로 성장하여 52억 9,000만 달러에 달할 것으로 예측됩니다.

이식형 제세동기(ICD)는 심장의 리듬을 지속적으로 모니터링하고 제세동, 페이싱 등의 전기적 치료를 시행하기 위해 외과적으로 이식하는 의료기기입니다. 이를 통해 생명을 위협하는 부정맥을 교정하고 갑작스러운 심장마비를 예방할 수 있습니다. 세계 시장 확대는 심혈관질환의 유병률 증가, 심장 질환에 취약한 고령화 인구, 장비의 효율성과 수명을 향상시키는 기술 발전에 힘입어 성장하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	36억 2,000만 달러
시장 규모 : 2030년	52억 9,000만 달러
CAGR : 2025-2030년	6.53%
가장 빠르게 성장하는 부문	T-ICD
최대 시장	북미

주요 시장 촉진요인

심혈관질환 및 갑작스런 심장마비 발생률의 증가는 전 세계 이식형 제세동기(ICD) 시장의 주요 촉진요인으로 작용하고 있습니다. 인구 고령화와 생활습관의 변화로 인해 새로운 심장 위험 요인이 발생함에 따라 ICD 치료가 필요한 생명을 위협하는 부정맥의 위험에 처한 환자 수가 증가하고 있습니다.

주요 시장 과제

세계 이식형 제세동기 시장이 직면한 주요 과제는 기기 이식 및 장기적인 환자 관리와 관련된 막대한 비용입니다. 이러한 큰 경제적 장벽은 특히 의료 인프라가 아직 개발 중인 지역에서 환자들이 필요한 치료를 받을 수 있는 기회를 직접적으로 제한하고 있습니다.

주요 시장 동향

인공지능(AI)과 머신러닝은 진단 정확도를 높이고 치료를 최적화함으로써 전 세계 이식형 제세동기 시장에 큰 영향을 미치고 있습니다. 이러한 기술을 통해 ICD는 방대한 심장 데이터를 분석하여 맞춤형 치료를 가능하게 합니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 이식형 제세동기(ICD) 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(경정맥형 이식형 제세동기, 피하형 이식형 제세동기)
  • 종류별(단실형 ICD, 이실형 ICD, 양심실형 디바이스)
  • NYHA 분류별(NYHA 클래스 II, NYHA 클래스 III)
  • 최종사용자별(병원, 외래 수술 센터, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 이식형 제세동기(ICD) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 이식형 제세동기(ICD) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 이식형 제세동기(ICD) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 이식형 제세동기(ICD) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 이식형 제세동기(ICD) 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 이식형 제세동기(ICD) 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Abbott Laboratories Inc.
• Medtronic Plc
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• MicroPort Scientific Corporation
• LivaNova PLC

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Implantable Cardioverter Defibrillator Market, valued at USD 3.62 Billion in 2024, is projected to experience a CAGR of 6.53% to reach USD 5.29 Billion by 2030. An Implantable Cardioverter Defibrillator (ICD) is a medical device surgically placed to continuously monitor cardiac rhythm and deliver electrical therapy, such as defibrillation or pacing, to correct life-threatening arrhythmias and prevent sudden cardiac arrest. The global market's expansion is driven by the increasing prevalence of cardiovascular diseases, an aging population more susceptible to cardiac conditions, and technological advancements enhancing device efficiency and longevity.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 3.62 Billion
Market Size 2030	USD 5.29 Billion
CAGR 2025-2030	6.53%
Fastest Growing Segment	T-ICDs
Largest Market	North America

Key Market Drivers

The increasing incidence of cardiovascular diseases and sudden cardiac arrest serves as a primary driver for the global implantable cardioverter defibrillator market. As populations age and lifestyles introduce new cardiac risk factors, the number of individuals susceptible to life-threatening arrhythmias requiring ICD therapy expands. These critical cardiac events necessitate effective interventions to prevent sudden cardiac death and improve patient outcomes.

Key Market Challenges

A primary challenging factor confronting the global implantable cardioverter defibrillator market is the considerable expenditure associated with both device implantation and subsequent long-term patient care. These substantial financial hurdles directly restrict patient access to necessary therapy, particularly within regions characterized by developing healthcare infrastructures. This limitation on accessibility translates into a slower adoption rate for implantable cardioverter defibrillators, thereby impeding the overall market expansion.

Key Market Trends

Artificial intelligence and machine learning are significantly impacting the Global Implantable Cardioverter Defibrillator Market by enhancing diagnostic precision and optimizing therapy. These technologies empower ICDs to analyze vast cardiac data for personalized treatment. The 2025 Scientific Statement from the European Heart Rhythm Association, Heart Rhythm Society, and ESC Working Group on E-Cardiology highlighted AI's potential in advanced arrhythmia detection and outcome prediction.

Key Market Players

• Abbott Laboratories Inc.
• Medtronic Plc
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• MicroPort Scientific Corporation
• LivaNova PLC

Report Scope:

In this report, the Global Implantable Cardioverter Defibrillator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Implantable Cardioverter Defibrillator Market, By Product:

• Transvenous Implantable Cardioverter Defibrillators
• Subcutaneous Implantable Cardioverter Defibrillators

Implantable Cardioverter Defibrillator Market, By Type:

• Single Chamber ICDs
• Dual Chamber ICDs
• Biventricular Devices

Implantable Cardioverter Defibrillator Market, By NYHA Class:

• NYHA Class II
• NYHA Class III

Implantable Cardioverter Defibrillator Market, By End-User:

• Hospitals
• Ambulatory Surgical Centers
• Others

Implantable Cardioverter Defibrillator Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Implantable Cardioverter Defibrillator Market.

Available Customizations:

Global Implantable Cardioverter Defibrillator Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Implantable Cardioverter Defibrillator Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators)
  • 5.2.2. By Type (Single Chamber ICDs, Dual Chamber ICDs, Biventricular Devices)
  • 5.2.3. By NYHA Class (NYHA Class II, NYHA Class III)
  • 5.2.4. By End-User (Hospitals, Ambulatory Surgical Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Implantable Cardioverter Defibrillator Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By NYHA Class
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Implantable Cardioverter Defibrillator Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By NYHA Class
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada Implantable Cardioverter Defibrillator Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By NYHA Class
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico Implantable Cardioverter Defibrillator Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By NYHA Class
      • 6.3.3.2.4. By End-User

7. Europe Implantable Cardioverter Defibrillator Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By NYHA Class
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By NYHA Class
      • 7.3.1.2.4. By End-User
  • 7.3.2. France Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By NYHA Class
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By NYHA Class
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By NYHA Class
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain Implantable Cardioverter Defibrillator Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By NYHA Class
      • 7.3.5.2.4. By End-User

8. Asia Pacific Implantable Cardioverter Defibrillator Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By NYHA Class
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By NYHA Class
      • 8.3.1.2.4. By End-User
  • 8.3.2. India Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By NYHA Class
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By NYHA Class
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By NYHA Class
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia Implantable Cardioverter Defibrillator Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By NYHA Class
      • 8.3.5.2.4. By End-User

9. Middle East & Africa Implantable Cardioverter Defibrillator Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By NYHA Class
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Implantable Cardioverter Defibrillator Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By NYHA Class
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE Implantable Cardioverter Defibrillator Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By NYHA Class
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa Implantable Cardioverter Defibrillator Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By NYHA Class
      • 9.3.3.2.4. By End-User

10. South America Implantable Cardioverter Defibrillator Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By NYHA Class
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Implantable Cardioverter Defibrillator Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By NYHA Class
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia Implantable Cardioverter Defibrillator Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By NYHA Class
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina Implantable Cardioverter Defibrillator Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By NYHA Class
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Implantable Cardioverter Defibrillator Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic Plc
• 15.3. Biotronik SE & Co. KG
• 15.4. Boston Scientific Corporation
• 15.5. MicroPort Scientific Corporation
• 15.6. LivaNova PLC

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료